Morbidity rate of depression
Pro Research Analysisby 
Searched over 200M research papers
Morbidity Rate of Depression: A Comprehensive Overview
Prevalence of Depression Morbidity
General Population Prevalence
Depression is a significant public health concern with varying prevalence rates across different populations. Recent epidemiological surveys indicate that the lifetime prevalence of depression ranges from 10% to 15% globally, with a 12-month prevalence varying from 3% in Japan to over 9% in the United States3. In the US, the prevalence of current depression is around 9%, with major depression affecting approximately 3.4% of the population3.
Older Adults
In a study conducted in Brazil among community residents aged 60 years and older, the one-month prevalence of depression morbidity was found to be 22%, with higher rates in women (25.2%) compared to men (18%)1. Factors such as younger age within the elderly group, low income, rural origin, poor self-rated health, and presence of systemic illnesses were significantly associated with higher depression morbidity1.
Trends Over Time
From 2005 to 2015, the prevalence of major depression in the US increased significantly, particularly among the youngest and oldest age groups, men, women, Non-Hispanic White persons, and those in the lowest income group6. The rate of increase in depression was notably more rapid among youth compared to older age groups6.
Depression and Co-Morbidities
Diabetes and Depression
Depression is a common co-morbidity in patients with diabetes. The prevalence of depression is more than three times higher in individuals with type 1 diabetes and nearly twice as high in those with type 2 diabetes compared to those without diabetes8. A meta-analysis revealed that approximately 28% of adults with type 2 diabetes experience depression, with higher rates observed in women compared to men9.
Multiple Morbidities
The prevalence of depression increases with the number of co-existing morbidities. For instance, individuals with concurrent diabetes, coronary heart disease, and stroke exhibit a very high prevalence of depression (23% in men and 49% in women)7. Depression in these patients is associated with higher healthcare utilization and increased costs7.
Impact of Depression on Morbidity and Mortality
Functional Impairment and Disability
Depression significantly impacts functional impairment and disability, leading to decreased workplace productivity and increased absenteeism. In the US, the economic burden due to absenteeism and presenteeism (being present at work but functioning suboptimally) is estimated to result in a loss of $36.6 billion per year3.
Mortality Risk
Depression is associated with a markedly increased risk of mortality, particularly from suicide and cardiovascular diseases. The mortality risk for suicide in depressed patients is more than 20-fold greater than in the general population3. Additionally, severe depression is linked to a 4 to 5 times higher long-term risk of suicide compared to mild or moderate depression4. Depression also increases the risk of cardiac mortality following a myocardial infarction and is related to the severity of the depressive episode3.
Conclusion
Depression morbidity is a pervasive issue with significant implications for public health. The prevalence of depression varies across different populations and is influenced by factors such as age, gender, income, and the presence of co-morbid conditions. The impact of depression extends beyond mental health, contributing to increased mortality, functional impairment, and economic burden. Addressing depression through effective treatment and preventive measures is crucial to mitigate its widespread effects on individuals and society.
Sources and full results
Most relevant research papers on this topic